Devices

Diabetes technology safety has become a critical focus as continuous glucose monitors (CGMs), insulin pumps, and automated insulin delivery systems transform diabetes care. These tools improve glycemic outcomes, enhance quality of life, and support proactive management. However, with increased device complexity comes a unique set of risks clinicians must recognize …

Traditional diabetes follow up guidelines suggest patients return for checkups at fixed intervals — often every three to six months. But are these schedules truly effective in today’s tech-enabled world? With tools like continuous glucose monitoring (CGM), telehealth, and patient risk scoring, it may be time to rethink how often …

In the era of smartphones, continuous glucose monitoring (CGM), remote portals, and health apps, digital tools offer powerful ways to support people living with diabetes. However, too much technology can overwhelm patients, leading to digital health fatigue in diabetes—a state where users disengage from tools that were meant to help …

For decades, clinicians have relied on A1C as the primary benchmark for diabetes control. Yet many patients and providers now wonder: does a single quarterly number truly reflect daily glucose fluctuations and risks? As continuous glucose monitoring (CGM) becomes more accessible, the metric known as Time in Range (TIR) has …

Could continuous glucose monitoring (CGM) soon become the norm in primary care? Once considered a specialty tool reserved for endocrinologists, CGM is now recommended far earlier in diabetes treatment — even for patients with type 2 diabetes on basal insulin alone. Despite these guideline shifts, primary care adoption has lagged. …

In the SWEET project experience, a large cohort of patients was started on either an insulin pump, glucose sensor, or both to compare the HbA1c levels and weight gain while on their new therapy.

The seventh-generation (G7) continuous glucose monitor provides accurate and safe glucose readings during 10.5 days of use among adults that have diabetes. 

Results from using GlucosePATH in Medicaid patients reveal the benefits of clinical decision support software in reducing HbA1c, reducing the risk of disease complications, and improving access to care. 

Fitness trackers are affordable and popular, but do they correlate with better physical activity levels in people with diabetes or other with cardiometabolic conditions?

Digital health companies have innovated ways to help individuals eat healthily and make better food choices.